- Home
- PVLA vs MBWM Comparison
PVLA vs MBWM Comparison
Compare PVLA & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- MBWM
- Stock Information
- Founded
- PVLA 2015
- MBWM 1997
- Country
- PVLA United States
- MBWM United States
- Employees
- PVLA N/A
- MBWM N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- MBWM Major Banks
- Sector
- PVLA Health Care
- MBWM Finance
- Exchange
- PVLA Nasdaq
- MBWM Nasdaq
- Market Cap
- PVLA 888.0M
- MBWM 740.5M
- IPO Year
- PVLA N/A
- MBWM 1997
- Fundamental
- Price
- PVLA $81.40
- MBWM $43.80
- Analyst Decision
- PVLA Strong Buy
- MBWM Buy
- Analyst Count
- PVLA 13
- MBWM 4
- Target Price
- PVLA $99.38
- MBWM $52.88
- AVG Volume (30 Days)
- PVLA 163.2K
- MBWM 54.8K
- Earning Date
- PVLA 11-11-2025
- MBWM 10-21-2025
- Dividend Yield
- PVLA N/A
- MBWM 3.34%
- EPS Growth
- PVLA N/A
- MBWM 6.26
- EPS
- PVLA N/A
- MBWM 5.27
- Revenue
- PVLA N/A
- MBWM $233,714,000.00
- Revenue This Year
- PVLA N/A
- MBWM $10.44
- Revenue Next Year
- PVLA N/A
- MBWM $11.11
- P/E Ratio
- PVLA N/A
- MBWM $8.63
- Revenue Growth
- PVLA N/A
- MBWM 5.19
- 52 Week Low
- PVLA $11.17
- MBWM $37.76
- 52 Week High
- PVLA $85.30
- MBWM $52.98
- Technical
- Relative Strength Index (RSI)
- PVLA 59.88
- MBWM 41.68
- Support Level
- PVLA $78.99
- MBWM $43.00
- Resistance Level
- PVLA $85.03
- MBWM $46.33
- Average True Range (ATR)
- PVLA 5.58
- MBWM 1.27
- MACD
- PVLA -0.02
- MBWM 0.06
- Stochastic Oscillator
- PVLA 63.39
- MBWM 30.68
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.